Non-cancer pain

Phase 3, randomized, double-blind, active-controlled, parallel arm study of PRC-062 (hydromorphone/naloxone controlled release capsules) in patients with chronic non-cancer pain. To see if IP is as effective as hydromorph contin.

Register Today!

Let others know about this Trial!

Trial Information

Trial Duration6 weeks
Number of Visits7
Lead CRCJason Collin

For additional information
on this trial contact: